Investing.com -- Shares of Biohaven Ltd. (NYSE: BHVN) climbed 7% as the company announced the FDA's acceptance and Priority Review of its troriluzole New Drug Application (NDA) for the treatment of ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

GENEVA - The World Health Organisation (WHO) launched on Feb 11 a new platform providing cost-free cancer medicines for thousands of children living in low- and middle-income countries, in a bid to ...

A second subtype of H5 bird flu, known as D1.1, was detected in dairy cattle and infected one worker in the US state of ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

HOUSTON - Moleculin Biotech, Inc. (NASDAQ:MBRX), a late-stage pharmaceutical company currently trading near its 52-week low of $0.66, announced it has received the first European regulatory approval ...

Spinocerebellar Ataxia (SCA) is a rare, genetic, life-threatening neurodegenerative disease with no available treatment. Troriluzole demonstrated a 50-70% slowing of SCA disease progression ...

Medicine shortages, preventive care, and mental health reform top priority list of new Belgian government says Health Minister Vandenbroucke.

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net cash provided by operating activities of $743 million in ...

Paris is one of many cities around the world grappling with how to adapt and design urban areas as climate change drives more ...

A recent major OECD report has warned of a looming crisis in the European health workforce. In the third in our series on the ...